Physician profile
Daniel S Welling
NPI 1427152644
$639.24
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $94.41 · 2021: $78.73 · 2022: $16.88 · 2023: $106 · 2024: $25.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $77.74 | 2019 | |
| Abbvie INC. | $69.07 | 2019-2023 | Liletta |
| Therapeuticsmd, INC. | $66.99 | 2019-2020 | |
| Duchesnay USA Incorporated | $60.78 | 2019 | |
| Minerva Surgical, INC | $37.02 | 2020-2024 | |
| Pfizer INC. | $30.16 | 2023 | |
| Astellas Pharma US INC | $29.64 | 2023 | Veozah |
| Amag Pharmaceuticals, INC. | $29.19 | 2019 | |
| Sumitomo Pharma America, INC. | $25.81 | 2023 | Myfembree |
| Ethicon US, LLC | $25.40 | 2020 | |
| Exeltis, USA INC. | $21.28 | 2021 | |
| Covidien Lp | $20.78 | 2019 | |
| Urovant Sciences INC | $20.39 | 2021 | |
| Myovant Sciences INC. | $19.97 | 2021 | |
| Lupin INC. | $17.35 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $17.09 | 2021 | |
| Organon LLC | $16.88 | 2022 | |
| Coopersurgical, INC. | $16.33 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.51 | 2019 | |
| Avion Pharmaceuticals | $12.88 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Welling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.